The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Will The Market Size Of The Stem Cell/Cord Blood Banking Market Evolve From 2026 To 2030?
The stem cell/cord blood banking market size has experienced swift expansion in recent years. It is projected to increase from $13.33 billion in 2025 to $15.01 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.7%. The growth observed in the historical period stems from factors such as increased private banking adoption, a rise in medical awareness, enhancements in storage technologies, established regulatory frameworks, and various marketing initiatives.
The stem cell/cord blood banking market is anticipated to undergo significant expansion in the coming years, with its size projected to reach $24.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This projected growth is driven by factors such as broadened therapeutic uses, enhancements in affordability, penetration into emerging markets, collaborations with hospitals, and an increasing need for long-term storage. Prominent trends expected during this forecast period include the rise in private cord blood storage, the adoption of hybrid public-private banking models, a wider range of stem cell applications, advancements in cryogenic storage, and various consumer awareness campaigns.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2514&type=smp
What Major Drivers Are Influencing Demand In The Stem Cell/Cord Blood Banking Market?
The increasing occurrence of chronic illnesses is anticipated to drive the expansion of the stem cell/cord blood banking market in the future. A chronic disease is defined as a type of ailment persisting for at least three months, which may worsen over time. Given that chronic conditions frequently lack adequate cures, the reparative capabilities of stem cells and cord blood are being progressively investigated for medical applications. The growth in stem cell transplantation, individualized medicine, and clinical studies exploring innovative treatments for chronic ailments is generating a greater need for banking provisions. For example, in February 2024, the World Health Organization, an intergovernmental entity located in Switzerland, forecast that by 2050, more than 35 million new cancer cases would arise, marking a 77% surge from the approximately 20 million cases recorded in 2022. Consequently, the growing frequency of chronic diseases is fueling the development of the stem cell or cord blood banking market.
Which Segment Areas Are Covered In The Stem Cell/Cord Blood Banking Market Analysis?
The stem cell/cord blood banking market covered in this report is segmented –
1) By Cell Type: Adult Stem Cells, Umbilical Cord Blood Stem Cells, Embryonic Stem Cells
2) By Service: Collection, Processing, Analysis, Storage
3) By Bank Type: Public, Private
4) By Application: Leukemia, Anemia, Thalassemia, Autism, Cerebral Palsy, Diabetes, Other Applications
Subsegments:
1) By Adult Stem Cells: Hematopoietic Stem Cells (HSC), Mesenchymal Stem Cells (MSC), Neural Stem Cells (NSC), Induced Pluripotent Stem Cells (iPSCs)
2) By Umbilical Cord Blood Stem Cells: Hematopoietic Stem Cells (HSC) From Cord Blood, Mesenchymal Stem Cells (MSC) From Cord Blood
3) By Embryonic Stem Cells: Embryonic Stem Cells (ESCs) From Human Embryos, Stem Cells Derived From Human Embryonic Germ Cells
Which Market Trends Are Creating New Opportunities In The Stem Cell/Cord Blood Banking Market?
Leading companies in the stemcell/cord blood banking market are developing peripheral blood stem cell processing and storage services to gain a competitive advantage. This service involves the collection, processing, testing, and cryopreservation of haematopoietic stem cells (HSCs) obtained from a patient’s peripheral blood. For instance, in February 2023, Cordlife Group Limited, a Singapore-based healthcare company, launched a new peripheral blood stem cell (PBSC) processing and storage service in Singapore. This offering is designed to support patients requiring haematopoietic stem cell transplantation as part of their treatment for various blood-related diseases, including leukemia, myeloma, and lymphoma. Cordlife’s collaboration with the Centre for Clinical Haematology (CFCH) allows eligible patients to undergo stem cell mobilization and harvesting, with Cordlife managing the subsequent processing, testing, and cryopreservation of PBSCs. This new service aims to improve treatment outcomes for individuals needing haematopoietic stem cell transplants and expand Cordlife’s range of banking services in Singapore.
Which Global Companies Are Actively Competing In The Stem Cell/Cord Blood Banking Market?
Major companies operating in the stem cell/cord blood banking market are Cryo-Cell International Inc, Esperite NV, Americord Registry LLC, China Cord Blood Corporation, Cordlife Group Ltd, CordVida, Cryo Stemcell, ReeLabs Pvt Ltd, Smart Cells International Ltd, Stemade Biotech Pvt Ltd, ViaCord Inc, LifeCell International, Cryoviva Biotech Pvt Ltd, Cord Blood America Inc, StemCyte Inc, Cord Blood Registry Systems Inc, Healthbanks Biotech Usa Inc, Cryo-save Private Ltd, New York Cord Blood Center, CryoHoldco, Vita 34 International AG, Reliance Life Sciences Pvt Ltd, Maze Cord Blood Laboratories, Cells4Life Group LLP
Read the full stem cell/cord blood banking market report here:
https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report
Which Region Shows The Strongest Potential For Future Growth In The Stem Cell/Cord Blood Banking Market?
North America was the largest region in the stem cell/cord blood banking market in 2025. Western Europe was the second largest region in the stem cell/cord blood banking market analysis. The regions covered in the stem cell/cord blood banking market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Stem Cell/Cord Blood Banking Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2514&type=smp
Browse Through More Reports Similar to the Global Stem Cell/Cord Blood Banking Market 2026, By The Business Research Company
Blood Bank Global Market Report
https://www.thebusinessresearchcompany.com/report/blood-bank-global-market-report
Stem Cell Assay Global Market Report
https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report
Blood Collection Devices Global Market Report
https://www.thebusinessresearchcompany.com/report/blood-collection-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model